PL3377071T3 - Oligosacharydy mleka ludzkiego do leczenia powikłań związanych z antybiotykami - Google Patents

Oligosacharydy mleka ludzkiego do leczenia powikłań związanych z antybiotykami

Info

Publication number
PL3377071T3
PL3377071T3 PL16865816.9T PL16865816T PL3377071T3 PL 3377071 T3 PL3377071 T3 PL 3377071T3 PL 16865816 T PL16865816 T PL 16865816T PL 3377071 T3 PL3377071 T3 PL 3377071T3
Authority
PL
Poland
Prior art keywords
human milk
milk oligosaccharides
associated complications
antibiotic associated
treating antibiotic
Prior art date
Application number
PL16865816.9T
Other languages
English (en)
Inventor
Bruce Mcconnell
Louise Kristine VIGSNÆS
David Paul KRONLAGE
Original Assignee
Glycom A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycom A/S filed Critical Glycom A/S
Publication of PL3377071T3 publication Critical patent/PL3377071T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL16865816.9T 2015-11-17 2016-11-17 Oligosacharydy mleka ludzkiego do leczenia powikłań związanych z antybiotykami PL3377071T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562256170P 2015-11-17 2015-11-17
US201662299186P 2016-02-24 2016-02-24
US201662345959P 2016-06-06 2016-06-06
PCT/DK2016/050371 WO2017084673A1 (en) 2015-11-17 2016-11-17 Synthetic Composition for Treating Antibiotic Associated Complications

Publications (1)

Publication Number Publication Date
PL3377071T3 true PL3377071T3 (pl) 2024-06-24

Family

ID=58717396

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16865816.9T PL3377071T3 (pl) 2015-11-17 2016-11-17 Oligosacharydy mleka ludzkiego do leczenia powikłań związanych z antybiotykami

Country Status (6)

Country Link
US (2) US10864224B2 (pl)
EP (1) EP3377071B1 (pl)
CN (1) CN108348536B (pl)
ES (1) ES2975018T3 (pl)
PL (1) PL3377071T3 (pl)
WO (1) WO2017084673A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
US10987368B2 (en) * 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
PL3377071T3 (pl) * 2015-11-17 2024-06-24 Glycom A/S Oligosacharydy mleka ludzkiego do leczenia powikłań związanych z antybiotykami
WO2017190754A1 (en) 2016-05-05 2017-11-09 Glycom A/S Composition comprising hmos for the treatment of non-infectious diarrhoea
EP3478093A4 (en) 2016-07-01 2020-03-04 Evolve Biosystems, Inc. METHOD FOR FACILITATING MATURATION OF THE MAMMALIAN IMMUNE SYSTEM
BR112021011071A2 (pt) * 2018-12-19 2021-08-31 Glycom A/S Composição e método para o tratamento de seres humanos utilizando dietas com baixo teor de fodmap
US20220378809A1 (en) * 2019-11-14 2022-12-01 Glycom A/S Synthetic composition for balancing the bile acid profile in the intestine
JP2023502260A (ja) * 2019-11-20 2023-01-23 アボット・ラボラトリーズ クロストリジウム・ディフィシル感染症を治療する栄養組成物
CN112870233B (zh) * 2019-11-29 2024-08-23 伊利伊诺科技(上海)有限责任公司 包含乳双歧杆菌与母乳低聚糖的组合物及其应用
WO2021191469A1 (en) * 2020-03-27 2021-09-30 Basf Se Composition for the treatment of gastro-intestinal dysfunction and/or associated morbidities thereto

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
PT1991690E (pt) 2006-03-09 2014-04-22 Centre Nat Rech Scient Método para a produção de oligossacáridos sialilados
EP1993577B1 (en) 2006-03-10 2014-02-12 N.V. Nutricia Use of non-digestable sacharides for giving an infant the best start after birth
US8197872B2 (en) * 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
ES2600481T3 (es) 2007-10-11 2017-02-09 Promovita Ingredients Limited Preparación para tratar una infección intestinal que comprende oligosacáridos y material celular insoluble
RU2478309C2 (ru) 2007-12-21 2013-04-10 Н.В. Нютрисиа Применение сфингомиелина и неперевариваемых углеводов для нормализации микробиоты кишечника
US8927027B2 (en) 2008-12-02 2015-01-06 Prolacta Bioscience Human milk permeate compositions and methods of making and using same
EP2405524B1 (en) 2009-03-05 2015-10-07 Nissan Motor Co., Ltd. Bipolar secondary cell and method for producing the same
WO2010115934A1 (en) 2009-04-07 2010-10-14 Glycom A/S Synthesis of 2'-o-fucosyllactose
US8993740B2 (en) 2010-02-19 2015-03-31 Glycom A/S Method for preparation of the tetrasaccharide lacto-N-neotetraose (LNnt) containing N-acetyllactosamine
ES2680920T3 (es) * 2010-07-12 2018-09-11 The Regents Of The University Of California Oligosacáridos de leche bovina
SG191393A1 (en) * 2010-12-31 2013-08-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
US20140057868A1 (en) 2011-02-21 2014-02-27 Glycom A/S Catalytic hydrogenolysis of a composition of a mixture of oligosaccharide precursors and uses thereof
CN103443113A (zh) 2011-03-18 2013-12-11 格力康公司 新型含岩藻糖的糖类衍生物的合成
RU2013155453A (ru) 2011-05-13 2015-06-20 Глюком А/С Диверсификация молочных олигосахаридов человека (hmos) или их предшественников
JP6129821B2 (ja) 2011-05-13 2017-05-17 グリコシン リミテッド ライアビリティー カンパニー プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用
US20140323705A1 (en) 2011-05-13 2014-10-30 Markus Hederos Manufacture of lacto-n-tetraose
RU2013155452A (ru) 2011-05-13 2015-06-20 Глюком А/С СПОСОБ ПОЛУЧЕНИЯ МОЛОЧНЫХ ОЛИГОСАХАРИДОВ ЧЕЛОВЕКА (HMOs) ИЛИ ИХ ПРЕДШЕСТВЕННИКОВ
EP2522232A1 (en) * 2011-05-13 2012-11-14 Nestec S.A. Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
SG2014013478A (en) * 2011-08-29 2014-05-29 Abbott Lab Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
WO2013044928A1 (en) 2011-09-30 2013-04-04 Glycom A/S Synthesis of hmo core structures
WO2013091660A1 (en) 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
US20150065702A1 (en) 2012-03-20 2015-03-05 Glycom A/S Synthesis of the Trisaccharide 3-O-Fucosyllactose and Intermediates Thereof
US20150265661A1 (en) * 2012-04-13 2015-09-24 Trustees Of Boston College Prebiotic effect of sialyllactose
US10364449B2 (en) 2013-09-06 2019-07-30 Glycom A/S Fermentative production of oligosaccharides
CN111172220B (zh) 2013-09-06 2023-08-04 格礼卡姆股份公司 寡糖的发酵生产
WO2015071131A1 (en) * 2013-11-15 2015-05-21 Nestec S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by c-section
WO2015095747A1 (en) 2013-12-20 2015-06-25 Abbott Laboratories Oral rehydration composition with oligosaccharides
CN106132420A (zh) * 2014-04-08 2016-11-16 雅培公司 使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
PL3377071T3 (pl) * 2015-11-17 2024-06-24 Glycom A/S Oligosacharydy mleka ludzkiego do leczenia powikłań związanych z antybiotykami

Also Published As

Publication number Publication date
US10864224B2 (en) 2020-12-15
US11998558B2 (en) 2024-06-04
EP3377071A4 (en) 2019-08-14
CN108348536B (zh) 2021-09-24
US20180325929A1 (en) 2018-11-15
EP3377071A1 (en) 2018-09-26
US20210100822A1 (en) 2021-04-08
CN108348536A (zh) 2018-07-31
WO2017084673A1 (en) 2017-05-26
EP3377071B1 (en) 2024-01-10
ES2975018T3 (es) 2024-07-02

Similar Documents

Publication Publication Date Title
PL3377071T3 (pl) Oligosacharydy mleka ludzkiego do leczenia powikłań związanych z antybiotykami
SG11202000900SA (en) Microorganism for producing human milk oligosaccharide
EP3315142A4 (en) STERILIZATION APPARATUS
EP3332717A4 (en) TREATMENT DEVICE
EP3265053A4 (en) Methods for treating skin
IL253840A0 (en) Oral care system
IL269371A (en) Treatment methods
EP3280375A4 (en) Body massaging apparatus
HK1249432A1 (zh) 治療細菌感染的方法
SG11201700621XA (en) Antibiotic compositions for treating bacterial infections
EP3354288C0 (en) STERILIZATION DEVICE
EP3263152A4 (en) Medical treatment device
EP3463141A4 (en) SYSTEM FOR TREATING UNWANTED TISSUE
EP3352586A4 (en) NUTRITIONAL ANTICANCER TREATMENT
EP3720446A4 (en) HUMAN MILK OLIGOSACCHARIDES FOR THE TREATMENT OF MIGRAINE
EP3424467A4 (en) ANTIBACTERIAL APPARATUS FOR IN VIVO IMPLANTATION
EP3316693A4 (en) A process for treating milk
EP3095378A4 (en) Medical treatment system
GB201514303D0 (en) Bifidobacteria for treating cardiac conditions
IL256236A (en) Derived from anus for the treatment of bacterial infections
EP3424466A4 (en) ANTIBACTERIAL DEVICE FOR IN VIVO IMPLANTATION
EP3349746A4 (en) ANTIBIOTIC THERAPY
HUE052429T2 (hu) Összeállítás sebészeti kezeléshez
EP3393256C0 (en) PROCESSES FOR MANUFACTURING DAIRY PRODUCTS AND MILK DERIVATIVES
GB201604658D0 (en) Treatment for pain